Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis
NCT01736696
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Immunomodulation
Interventions
DRUG:
tofacitinib
DRUG:
tofacitinib
DRUG:
tofacitinib
DRUG:
tofacitinib
DRUG:
tofacitinib
DRUG:
tofacitinib
Sponsor
Pfizer